Cargando…
Major Histocompatibility Complex Genes as Therapeutic Opportunity for Immune Cold Molecular Cancer Subtypes
Current immunotherapies are effective only in a subset of patients, likely due to several factors including defects in tumor cell antigen presentation, decreased response to immune effectors, and molecular heterogeneity of cancers. Recent molecular classifications enable the categorization of many t...
Autores principales: | Karpiński, Paweł, Łaczmański, Łukasz, Sąsiadek, Maria M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685841/ https://www.ncbi.nlm.nih.gov/pubmed/33282963 http://dx.doi.org/10.1155/2020/8758090 |
Ejemplares similares
-
Vitamin D receptor gene polymorphisms in relation to the risk of colorectal cancer in the Polish population
por: Laczmanska, Izabela, et al.
Publicado: (2014) -
Major Histocompatibility Complex I and II Expression and Lymphocytic Subtypes in Muscle of Horses with Immune‐Mediated Myositis
por: Durward‐Akhurst, S.A., et al.
Publicado: (2016) -
Mapping of the immune response genes in the major histocompatibility complex of the Rhesus monkey
Publicado: (1975) -
Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes
por: Okada, Yukinori, et al.
Publicado: (2014) -
The Major Histocompatibility Complex in Transplantation
por: Ayala García, Marco Antonio, et al.
Publicado: (2012)